Key result
Electronegative LDL subfractions drive ASCVD in autoimmune rheumatic diseases via LOX-1 and inflammasome activation.
Answers are grounded in this paper and cite their sources.
Atherosclerosis has been linked with an increased risk of atherosclerotic cardiovascular disease (ASCVD). Autoimmune rheumatic diseases (AIRDs) are associated with accelerated atherosclerosis and ASCVD. However, the mechanisms underlying the high ASCVD burden in patients with AIRDs cannot be explained only by conventional risk factors despite disease-specific factors and chronic inflammation. Nevertheless, the normal levels of plasma low-density lipoprotein (LDL) cholesterol observed in most patients with AIRDs do not exclude the possibility of increased LDL atherogenicity. By using anion-exchange chromatography, human LDL can be divided into five increasingly electronegative subfractions, L1 to L5, or into electropositive and electronegative counterparts, LDL (+) and LDL (-). Electronegative L5 and LDL (-) have similar chemical compositions and can induce adverse inflammatory reactions in vascular cells. Notably, the percentage of L5 or LDL (-) in total LDL is increased in normolipidemic patients with AIRDs. Electronegative L5 and LDL (-) are not recognized by the normal LDL receptor but instead signal through the lectin-like oxidized LDL receptor 1 (LOX-1) to activate inflammasomes involving interleukin 1β (IL-1β). Here, we describe the detailed mechanisms of AIRD-related ASCVD mediated by L5 or LDL (-) and discuss the potential targeting of LOX-1 or IL-1β signaling as new therapeutic modalities for these diseases.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2021) conducted a review in Autoimmune rheumatic diseases (AIRDs) and atherosclerotic cardiovascular disease (ASCVD). Electronegative L5 and LDL (-) / LOX-1 or IL-1β signaling was evaluated. Electronegative L5 and LDL (-) subfractions are increased in normolipidemic patients with autoimmune rheumatic diseases and signal through LOX-1 to activate IL-1β inflammasomes, driving ASCVD.
Synapse has enriched 10 related papers. Consider them for comparative context: